Back to search

Article

Daratumumab monotherapy for refractory lupus nephritis

2023-01-19

Abstract excerpt

<title>Abstract</title> <p>Refractory lupus nephritis (RLN) is a clinical condition with high risk of a poor outcome and often life-threatening. Six patients (one male and 5 females), aged 41.3 years (range 20 to 61 years) were treated with Daratumumab monotherapy, a monoclonal antibody targeting CD38 which is highly expressed on the surface of many immune cells, especially plasma cells. The treatment protocol co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7f58ae72-ce8d-5d6f-b5b0-ca79cb19e730
DOI
10.21203/rs.3.rs-2472742/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Daratumumab monotherapy for refractory lupus nephritisDOI 10.21203/rs.3.rs-2472742/v1
Top 10 developments in lupus nephritis.Semantic proximity
Lupus nephritis: the evolving role of novel therapeutics.Semantic proximity
Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity.Semantic proximity
Immune and molecular landscape behind non-response to Mycophenolate Mofetil and Azathioprine in lupus nephritis therapySemantic proximity
Peripheral CD4CD8 Double Positive T Cells: A Potential Marker to Evaluate Kidney Damage Susceptibility During SLESemantic proximity
Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.Semantic proximity
Pharmacokinetic characterization of rituximab in patients with glomerular diseasesSemantic proximity
Biologic therapies for lupus nephritis: a systematic review of efficacy, safety, and cost-effectivenessSemantic proximity
The Future of Systemic Lupus Erythematosus Treatment: The Promise of Selective Immunotherapies, Anifrolumab and Belimumab, Compared to Blanket ImmunosuppressivesSemantic proximity
Efficacy and safety of belimumab combined with the standard regimen in treating children with lupus nephritisSemantic proximity
Anifrolumab in Monogenic Lupus caused by TREX1 MutationSemantic proximity
Calcineurin inhibitor versus mycophenolate mofetil along with rituximab in non-genetic calcineurin inhibitor resistant steroid resistant nephrotic syndrome: retrospective observation from western India ​Semantic proximity
Select a neighboring publication to make it the new centre.